Home » AstraZeneca: Zinforo Gets EC Marketing Approval
AstraZeneca: Zinforo Gets EC Marketing Approval
AstraZeneca PLC, a biopharmaceutical business, said Tuesday the European Commission has granted marketing authorization to Zinforo [ceftaroline fosamil], a new intravenous cephalosporin antibiotic, for the treatment of adult patients with complicated skin and soft tissue infections [cSSTI] or community acquired pneumonia [CAP].
MarketWatch
MarketWatch
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May